Clinician Perspectives on Barriers and Facilitators to Implementing e-Health Technology in Substance Use Disorder (SUD) Treatment Facilities.

SUD Substance use disorder e-health mobile app

Journal

Substance abuse : research and treatment
ISSN: 1178-2218
Titre abrégé: Subst Abuse
Pays: United States
ID NLM: 101514834

Informations de publication

Date de publication:
2021
Historique:
received: 16 06 2021
accepted: 24 09 2021
entrez: 1 11 2021
pubmed: 2 11 2021
medline: 2 11 2021
Statut: epublish

Résumé

Substance use disorders (SUDs) in the United States cause many preventable deaths each year. Finding effective ways to manage SUDs is vital to improving outcomes for individuals seeking treatment. This has increased interest in using e-health technologies in behavioral healthcare settings. This research is part of a larger study evaluating the efficacy of the NIATx coaching intervention for implementing RISE Iowa, an e-health patient recovery app, in SUD treatment organizations and seeks to examine clinician perspectives of the barriers and facilitators to its implementation. Semi-structured qualitative interviews were conducted with 13 clinicians from 9 different intervention sites involved in the study. Major barriers to implementing e-health technology include inability to access the technology, lack of time for both patients and clinicians, and a perceived lack of patient motivation to make changes. Facilitators to implementation include collaboration with other staff using e-health technology and integrating technology use into typical workflows. Implementation of e-health technology in SUD treatment will require integrating the technology into clinical workflows and improving patient access to the technology.

Sections du résumé

BACKGROUND BACKGROUND
Substance use disorders (SUDs) in the United States cause many preventable deaths each year. Finding effective ways to manage SUDs is vital to improving outcomes for individuals seeking treatment. This has increased interest in using e-health technologies in behavioral healthcare settings. This research is part of a larger study evaluating the efficacy of the NIATx coaching intervention for implementing RISE Iowa, an e-health patient recovery app, in SUD treatment organizations and seeks to examine clinician perspectives of the barriers and facilitators to its implementation.
METHOD METHODS
Semi-structured qualitative interviews were conducted with 13 clinicians from 9 different intervention sites involved in the study.
RESULTS RESULTS
Major barriers to implementing e-health technology include inability to access the technology, lack of time for both patients and clinicians, and a perceived lack of patient motivation to make changes. Facilitators to implementation include collaboration with other staff using e-health technology and integrating technology use into typical workflows.
CONCLUSIONS CONCLUSIONS
Implementation of e-health technology in SUD treatment will require integrating the technology into clinical workflows and improving patient access to the technology.

Identifiants

pubmed: 34720585
doi: 10.1177/11782218211053360
pii: 10.1177_11782218211053360
pmc: PMC8552376
doi:

Types de publication

Journal Article

Langues

eng

Pagination

11782218211053360

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA044159
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002373
Pays : United States

Informations de copyright

© The Author(s) 2021.

Déclaration de conflit d'intérêts

Declaration of conflicting interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Todd Molfenter is a faculty member at CHESS. In addition to his academic affiliation, Dr. Molfenter has a less than .1% ownership with CHESS Health, the organization responsible for making the A-CHESS addiction recovery app commercially available to the public. Dr. Molfenter has worked extensively with his institution to manage any conflicts of interest. An external advisory board approved all survey instruments applied, and the individuals who will conduct the data collection and interpretation for this study will have no affiliation with CHESS Health. Also, parts of the NIATx organizational change model used in part of this trial were developed by the Center for Health Enhancement System Studies (CHESS) at the University of Wisconsin–Madison, where Dr. Molfenter is a faculty member. Dr. Molfenter is also affiliated with the NIATx Foundation, the organization responsible for making the NIATx organizational change model available to the public. For this scenario, Dr. Molfenter also has an institutionally approved plan to manage potential conflicts of interest. The individuals who will conduct the data collection and interpretation for this study manuscript will have no affiliation with the NIATx Foundation. David Gustafson is a part-owner of CHESS Health, devoted to marketing information technologies to agencies that deliver addiction treatment. He is also on the board of directors of the not-for-profit NIATx Foundation, as well as a small consulting company doing business as David H. Gustafson and Associates. These relationships do not carry with them any restrictions on publication, and any associated intellectual property will be disclosed and processed according to his institution’s policies.

Références

J Med Internet Res. 2020 May 26;22(5):e16906
pubmed: 32348285
Trans Am Clin Climatol Assoc. 2017;128:112-130
pubmed: 28790493
Drug Alcohol Depend. 2020 Oct 1;215:108201
pubmed: 32777691
Subst Abuse. 2016 Feb 14;10:1-7
pubmed: 26917964
JAMA Psychiatry. 2014 May;71(5):566-72
pubmed: 24671165
Amyotroph Lateral Scler Frontotemporal Degener. 2020 May;21(3-4):167-182
pubmed: 31878794
J Health Psychol. 2019 Oct;24(12):1668-1675
pubmed: 28810415
J Asthma. 2021 Apr;58(4):554-563
pubmed: 31868043
Implement Sci Commun. 2020 Sep 30;1:83
pubmed: 33015640
J Affect Disord. 2017 Aug 15;218:15-22
pubmed: 28456072
J Med Internet Res. 2019 Apr 08;21(4):e10859
pubmed: 30958270
Psychiatr Serv. 2018 Jan 1;69(1):69-75
pubmed: 28859586
Implement Sci. 2015 Feb 12;10:21
pubmed: 25889199
World Psychiatry. 2017 Oct;16(3):287-298
pubmed: 28941113
J Subst Abuse Treat. 2017 Jun;77:57-66
pubmed: 28476273
Subst Abuse Treat Prev Policy. 2012 May 02;7:16
pubmed: 22551101
J Contin Educ Health Prof. 2018 Spring;38(2):145-151
pubmed: 29505486
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
J Subst Abuse Treat. 2013 Mar;44(3):256-63
pubmed: 22898042
J Addict Med. 2021 Jul-Aug 01;15(4):341-344
pubmed: 33105169
Telemed J E Health. 2021 Feb;27(2):150-158
pubmed: 32746750
J Subst Abuse Treat. 2014 Jan;46(1):43-51
pubmed: 24060350
Am J Psychiatry. 2008 Jul;165(7):881-8
pubmed: 18450927
Implement Sci. 2020 Oct 23;15(1):94
pubmed: 33097097

Auteurs

Kathryn Fleddermann (K)

Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, WI, USA.

Todd Molfenter (T)

Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, WI, USA.

Nora Jacobson (N)

Institute for Clinical and Translational Research and School of Nursing, University of Wisconsin-Madison, Madison, WI, USA.

Julie Horst (J)

Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, WI, USA.

Mathew R Roosa (MR)

Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, WI, USA.

Deanne Boss (D)

Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, WI, USA.

J Charles Ross (JC)

Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, WI, USA.

Eric Preuss (E)

Bureau of Substance Abuse, Iowa Department of Public Health, Des Moines, IA, USA.

David H Gustafson (DH)

Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, WI, USA.

Classifications MeSH